The Community Resource in Targeted Therapies
Driving Knowledge. Empowering Change. Optimizing Outcomes.
ONCAlert | Upfront Therapy for mRCC

A Study of Nivolumab With Nab-Paclitaxel Plus Gemcitabine in Pancreatic Cancer

Gabriela Chiorean, MD
Published Online: 5:25 PM, Tue February 7, 2017

Gabriela Chiorean, MD, professor of medicine, discusses an ongoing phase I study of nivolumab with nab-paclitaxel plus gemcitabine in pancreatic cancer.

Copyright © TargetedOnc 2018 Intellisphere, LLC. All Rights Reserved.